We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.08B
AUM Growth
+$312M
(+4.6%)
Cap. Flow
+$423M
Cap. Flow
% of AUM
5.97%
Top 10 Holdings %
Top 10 Hldgs %
31.95%
Holding
1,367
New
348
Increased
332
Reduced
294
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$188M |
| 2 |
Labcorp
LH
|
+$183M |
| 3 |
AGN
Allergan Inc
AGN
|
+$144M |
| 4 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$93.8M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$82.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brookdale Senior Living
BKD
|
+$104M |
| 2 |
Cardinal Health
CAH
|
+$104M |
| 3 |
AGN
Allergan plc
AGN
|
+$80.7M |
| 4 |
AMAG
AMAG Pharmaceuticals
AMAG
|
+$60.3M |
| 5 |
Elevance Health
ELV
|
+$55.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 47.3% |
| 2 | Consumer Discretionary | 5.38% |
| 3 | Financials | 4.49% |
| 4 | Industrials | 3.37% |
| 5 | Technology | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
K
551
DELISTED
Kellanova
K
| $858K | 0.01% |
13,956
-2,832
| -17% | -$170K |
|
552
Axos Financial
AX
$5.6B
| $857K | 0.01% |
+43,968
| New | +$825K |
|
|
CNH
553
CNH Industrial
CNH
$12.8B
| $855K | 0.01% |
146,222
-3,342
| -2% | -$23.2K |
|
554
NOV
NOV
$6.93B
| $850K | 0.01% |
12,960
-10,020
| -44% | -$698K |
|
|
DD
555
DELISTED
Du Pont De Nemours E I
DD
| $850K | 0.01% |
+12,094
| New | +$808K |
|
556
Ball Corp
BALL
$17.4B
| $844K | 0.01% |
24,740
-47,092
| -66% | -$1.55M |
|
557
Chemed
CHE
$7.1B
| $840K | 0.01% |
+7,940
| New | +$839K |
|
558
Enerpac Tool Group
EPAC
$1.86B
| $831K | 0.01% |
+30,494
| New | +$910K |
|
559
AES
AES
$10.6B
| $828K | 0.01% |
60,093
+8,418
| +16% | +$115K |
|
|
STJ
560
DELISTED
St Jude Medical
STJ
| $825K | 0.01% |
12,680
+2,406
| +23% | +$155K |
|
561
F5
FFIV
$22.1B
| $823K | 0.01% |
6,301
+4,513
| +252% | +$563K |
|
562
iShares Russell 2000 ETF
IWM
$80.2B
| $818K | 0.01% |
6,828
+3,828
| +128% | +$438K |
|
|
ANN
563
DELISTED
ANN INC
ANN
| $813K | 0.01% |
+22,270
| New | +$839K |
|
564
NCR Voyix
VYX
$1.12B
| $795K | 0.01% |
44,432
+26,300
| +145% | +$462K |
|
565
Alerian MLP ETF
AMLP
$12.9B
| $794K | 0.01% |
9,060
+2,440
| +37% | +$221K |
|
566
Macy's
M
$6.56B
| $791K | 0.01% |
12,024
-4,112
| -25% | -$249K |
|
567
Lockheed Martin
LMT
$132B
| $785K | 0.01% |
4,076
-2,979
| -42% | -$553K |
|
|
RHT
568
DELISTED
Red Hat Inc
RHT
| $783K | 0.01% |
+11,318
| New | +$684K |
|
|
VISN
569
Vistance Networks Inc
VISN
$2.64B
| $782K | 0.01% |
+34,222
| New | +$764K |
|
570
SBA Communications
SBAC
$19.3B
| $779K | 0.01% |
+7,030
| New | +$791K |
|
|
DST
571
DELISTED
DST Systems Inc.
DST
| $778K | 0.01% |
16,520
+4,368
| +36% | +$204K |
|
|
TW
572
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
| $775K | 0.01% |
+6,840
| New | +$754K |
|
573
Reinsurance Group of America
RGA
$15.6B
| $769K | 0.01% |
8,769
-2,169
| -20% | -$181K |
|
574
H&R Block
HRB
$5.61B
| $768K | 0.01% |
22,774
-5,452
| -19% | -$175K |
|
|
CY
575
DELISTED
Cypress Semiconductor
CY
| $764K | 0.01% |
53,461
+43,074
| +415% | +$476K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q4 2014 Portfolio in Review
As of Q4 2014, Visium Asset Management held 1,367 positions worth $7.08B, up 4.6% from $6.77B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $423M of net new capital in Q4 2014, opening 348 new positions and adding to 332 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Brookdale Senior Living, an estimated $104M trimmed.
- Visium Asset Management's largest Q4 2014 buy was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.
- Visium Asset Management added most to COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014, an estimated $188M increase.
- Visium Asset Management's biggest Q4 2014 reduction was Brookdale Senior Living, cutting an estimated $104M.
- Visium Asset Management fully exited AMAG Pharmaceuticals in Q4 2014, selling an estimated $60.3M.
- Visium Asset Management's ten largest holdings make up 32% of its $7.08B portfolio in Q4 2014.
- Visium Asset Management opened 348 new positions and closed 358 in Q4 2014.
- Visium Asset Management's portfolio value rose 4.6% quarter-over-quarter to $7.08B.
Based on Visium Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.